MediPal Holdings Corporation
MAHLYOTCHealthcare● Active
$19.30
+$0.30(+1.58%)
Market Cap$4.0B
P/E Ratio—
52W High$20.35
52W Low$14.6
MediPal Holdings Corporation (MAHLY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MAHLY · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.048T | $3.671T | $3.559T | $3.360T | $3.291T |
| Cost of Revenue | $3.785T | $3.416T | $3.312T | $3.148T | $3.086T |
| Gross Profit | $0.262T | $0.256T | $0.247T | $0.212T | $0.205T |
| Gross Margin %(computed) | 6.48% | 6.97% | 6.93% | 6.31% | 6.23% |
| Operating Expenses | |||||
| R&D Expenses | $0.000T | $0.000T | $0.001T | $0.000T | $0.000T |
| G&A Expenses | $0.000T | $0.000T | $0.165T | $0.144T | $0.141T |
| Total Operating Expenses | $0.206T | $0.200T | $0.199T | $0.163T | $0.159T |
| Operating Income | $0.056T | $0.056T | $0.047T | $0.049T | $0.046T |
| Operating Margin %(computed) | 1.39% | 1.51% | 1.33% | 1.46% | 1.39% |
| Interest Income | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Interest Expense | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Income Before Tax | $0.087T | $0.077T | $0.075T | $0.070T | $0.057T |
| Income Tax Expense | $0.030T | $0.025T | $0.023T | $0.022T | $0.018T |
| Net Income | $0.045T | $0.040T | $0.041T | $0.039T | $0.029T |
| Net Margin %(computed) | 1.11% | 1.10% | 1.17% | 1.15% | 0.89% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $218.90 | $193.19 | $195.83 | $184.82 | $140.13 |
| Wtd Avg Shares | 0.000T | 0.000T | 0.000T | 0.000T | 0.000T |
| EBITDA | $0.086T | $0.095T | $0.065T | $0.064T | $0.060T |
| EBITDA Margin %(computed) | 2.13% | 2.59% | 1.84% | 1.89% | 1.82% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · JPY · T
Explore more MediPal Holdings Corporation data
About MediPal Holdings Corporation (MAHLY) Income Statement
MediPal Holdings Corporation (MAHLY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, MAHLY reported revenue of $4047.57B, gross profit of $262.33B (gross margin 6.48%), and net income of $45.10B — a net profit margin of 1.11%.
Frequently asked questions
MAHLY · 4 questionsMediPal Holdings Corporation (MAHLY) reported revenue of $4047.57B for 2026, up 10.2% year-over-year.
MAHLY revenueMAHLY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08